Pavion Blue Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $705K | Hold |
15,233
| – | – | 0.31% | 58 |
|
|
2025
Q1 | $929K | Hold |
15,233
| – | – | 0.44% | 47 |
|
|
2024
Q4 | $862K | Buy |
15,233
+1,000
| +7% | +$56.6K | 0.4% | 48 |
|
|
2024
Q3 | $736K | Hold |
14,233
| – | – | 0.34% | 57 |
|
|
2024
Q2 | $591K | Hold |
14,233
| – | – | 0.29% | 61 |
|
|
2024
Q1 | $772K | Sell |
14,233
-2,143
| -13% | -$116K | 0.38% | 54 |
|
|
2023
Q4 | $840K | Hold |
16,376
| – | – | 0.46% | 52 |
|
|
2023
Q3 | $950K | Hold |
16,376
| – | – | 0.58% | 46 |
|
|
2023
Q2 | $1.05M | Hold |
16,376
| – | – | 0.61% | 44 |
|
|
2023
Q1 | $1.14M | Hold |
16,376
| – | – | 0.7% | 40 |
|
|
2022
Q4 | $1.18M | Buy |
16,376
+25
| +0.2% | +$1.8K | 0.75% | 40 |
|
|
2022
Q3 | $1.16M | Hold |
16,351
| – | – | 0.83% | 34 |
|
|
2022
Q2 | $1.26M | Buy |
16,351
+102
| +0.6% | +$7.85K | 0.85% | 35 |
|
|
2022
Q1 | $1.19M | Buy |
16,249
+50
| +0.3% | +$3.65K | 0.7% | 37 |
|
|
2021
Q4 | $1.01M | Sell |
16,199
-121
| -0.7% | -$7.54K | 0.59% | 41 |
|
|
2021
Q3 | $966K | Buy |
16,320
+350
| +2% | +$20.7K | 0.6% | 42 |
|
|
2021
Q2 | $1.07M | Hold |
15,970
| – | – | 0.64% | 40 |
|
|
2021
Q1 | $1.01M | Hold |
15,970
| – | – | 0.66% | 40 |
|
|
2020
Q4 | $991K | Sell |
15,970
-69
| -0.4% | -$4.28K | 0.68% | 38 |
|
|
2020
Q3 | $967K | Hold |
16,039
| – | – | 0.74% | 37 |
|
|
2020
Q2 | $943K | Buy |
16,039
+2,700
| +20% | +$159K | 0.82% | 34 |
|
|
2020
Q1 | $744K | Buy |
+13,339
| New | +$744K | 0.77% | 34 |
|